Aminophenazone
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Aminophenazone
|
|
| Systematic (IUPAC) name | |
| 4-dimethylamino-1,5-dimethyl-2-phenylpyrazol-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | N02 |
| PubChem | |
| Chemical data | |
| Formula | C13H17N3O |
| Mol. mass | 231.29358 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Aminophenazone — a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis. A breath test with 13C-labeled aminopyrine has been used as a non-invasive measure of cytochrome P-450 metabolic activity in liver function tests.[1]
[edit] References
- ^ Aminophenazone — Compound Summary. PubChem. The National Library of Medicine. Retrieved on June, 12, 2008.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
